Please login to the form below

Not currently logged in
Email:
Password:

research consortium

This page shows the latest research consortium news and features for those working in and with pharma, biotech and healthcare.

Grünenthal research consortium receives €1.5m EU grant

Grünenthal research consortium receives €1.5m EU grant

Grünenthal research consortium receives 1.5m EU grant. Wins funding for development of efficacy testing in neuropathic pain treatments. ... A research consortium that aims to improve the development of new analgesic drugs has been awarded a 1.5m grant

Latest news

  • AstraZeneca embarks on oncology research access project AstraZeneca embarks on oncology research access project

    AstraZeneca embarks on oncology research access project. Invites companies to join molecular data resource consortium. ... AstraZeneca has launched a new collaborative venture to improve industry-wide access to oncology research, teaming up with software

  • Celgene takes aim at cancer innovation with new US research consortium Celgene takes aim at cancer innovation with new US research consortium

    Celgene takes aim at cancer innovation with new US research consortium. ... Academic tie-up aims to develop new therapeutics and diagnostics. Celgene has formed an academic research consortium to develop innovative new cancer therapeutics and diagnostics.

  • UK’s MRC launches public-private push on dementia research UK’s MRC launches public-private push on dementia research

    The UK Dementias Research Platform (UKDP) will draw on expertise from eight UK universities and six pharmaceutical companies, with other firms expected to join the consortium in the coming months. ... a research unit in the UK as a direct result of the

  • EU rules 'deny cancer therapy to children' EU rules 'deny cancer therapy to children'

    The UK Institute of Cancer Research (ICR) in London and European Consortium for Innovative Therapies for Children with Cancer (ITCC) in France have called for changes to the EU's 2007

  • Wanted: Social media innovation to detect AEs Wanted: Social media innovation to detect AEs

    The aim of the WEBAE - Leveraging Emerging Technology for Pharmacovigilance project is to form a specialist public private consortium that will research appropriate policy and technology solutions for using web-based

More from news
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • Making Europe a leader in bioscience: boosting trust and opening minds Making Europe a leader in bioscience: boosting trust and opening minds

    These are not short-term fashion trends based on only a few research publications. ... The best R&D clusters ecosystem brings together all the ingredients needed for success in collaborative research: the best scientific ideas, a critical mass of funding

  • EATRIS and the new age of partnering EATRIS and the new age of partnering

    It gained elite European Research Infrastructure Consortium status from the European Union in 2013 and has just staged its second annual conference - Building Bridges in Translational Medicine - where international speakers hailed ... to happen so we

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Marschall Runge joins Lilly’s board of directors Marschall Runge joins Lilly’s board of directors

    Dr Runge will serve on Lilly's Science and Technology Committee and the Public Policy and Compliance Committee, where he will use his years of experience in medicines research and healthcare ... Dr Runge also currently serves as principal investigator

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics